Denmark-based company Oxymat is optimistic about a new direction of growth for its oxygen generator technology, after a rule change by The European Pharmacopoeia Commission (PhEur).
From what gasworld understands, the monograph (study) for oxygen 93% was adopted by the commission at the 136th Session of the PhEur in Strasbourg, France, in March 2010.
Along with a number of other monographs either created or revised, the oxygen 93% study came into effect on 1st April 2011. According to a news item on the website of Oxymat, with 93% oxygen now accepted this could present big opportunities for medical oxygen PSA plants.
The change means that oxygen generators complying with the rules are now allowed on European Hospitals. This gives exciting new opportunities to sell not only to the European Market, but also to other geographical areas traditionally following the European legislations, Oxymat claims.
... to continue reading you must be subscribed
